SABRIL (vigabatrin) is a prescription medicine utilized with other therapies in children and grownups 2 years of age and older with refractory facility partial seizures (CPS) that have not responded well enough to a number of various other therapies and if the feasible advantages exceed the risk of vision loss.
It is recommended that your doctor test your (or your child's) vision prior to or within 4 weeks after beginning SABRIL and a minimum of every 3 months throughout treatment up until SABRIL is stopped. Inform your doctor if you or your youngster have any side effect that bothers you or that does not disappear.
Tell your healthcare provider if you are expectant or mean to get expecting. If vision screening can not be done, your healthcare provider may proceed suggesting SABRIL, but will not have the ability to watch for any kind of vision loss. Your health care service provider might quit recommending SABRIL for you (or your kid)if vision examinations are not done consistently.